Publication Name	World Journal of Pharmacology
Manuscript ID	22416
Country	United Kingdom

Received	2015-08-28 08:34
Peer-Review Started	2015-09-01 21:39
To Make the First Decision	2015-11-24 14:40
Return for Revision	2015-11-27 08:21
Revised	2015-12-11 06:17
Second Decision	2015-12-29 11:27
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2016-01-07 16:57
Articles in Press	2016-01-07 16:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-02-24 15:19
Publish the Manuscript Online	2016-03-04 15:35

ISSN	2220-3192 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Non-selective beta-blockers in cirrhosis: Current concepts and controversies
Manuscript Source	Invited Manuscript
All Author List	Neil Rajoriya and Dhiraj Tripathi
Funding Agency and Grant Number
Corresponding Author	Dr. Dhiraj Tripathi, Consultant Hepa­tologist, Honorary Senior Lecturer, Department of Hepatology, the New Queen Elizabeth Hospital, Edgbaston, Queen Elizabeth Medical Centre, Birmingham B15 2TH, United Kingdom. dhiraj.tripathi@uhb.nhs.uk
Key Words	Variceal haemorrhage; Non-selective beta-blockers; Portal hypertension; Liver cirrhosis
Core Tip	This article serves to discuss the changing role of non-selective beta-blockers in liver disease and portal hypertension. For many years non-selective beta-blockers have been at the forefront in reducing portal hypertensive complications such as variceal haemorr-hage, however recent data has questioned their role in advanced liver disease. This article reviews their role in portal hypertension, discusses recent advances in the field and reviews the controversy recently generated regarding their role in advanced liver disease.
Publish Date	2016-03-04 15:35
Citation	Rajoriya N, Tripathi D. Non-selective beta-blockers in cirrhosis: Current concepts and controversies. World J Pharmacol 2016; 5(1): 15-31
URL	http://www.wjgnet.com/2220-3192/full/v5/i1/15.htm
DOI	http://dx.doi.org/10.5497/wjp.v5.i1.15

Full Article (PDF)	WJP-5-15.pdf
Full Article (Word)	WJP-5-15.doc
Manuscript File	22416-Review.doc
Answering Reviewers	22416-Answering reviewers.pdf
Audio Core Tip	22416-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	22416-Conflict-of-interest statement.pdf
Copyright License Agreement	22416-Copyright assignment.pdf
Peer-review Report	22416-Peer-review(s).pdf
Scientific Misconduct Check	22416-Scientific misconduct check.pdf
Scientific Editor Work List	22416-Scientific editor work list.pdf